Literature DB >> 3199066

Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).

J L Rothstein1, T F Lint, H Schreiber.   

Abstract

TNF induces hemorrhagic necrosis (HN) when injected into skin exposed to bacterial agents but not when injected into normal skin. In this paper, we present several lines of evidence suggesting that TNF requires the fifth component of complement (C5) to induce HN in skin exposed to bacteria. First, mouse strains that do not have C5 did not develop HN after injection of TNF and bacteria into skin. Second, plasma from C5-sufficient mice could correct the defect in these C5-deficient mice. Third, heating at 56 degrees C for 30 min inactivated the capacity of plasma to reconstitute C5-deficient mice. Fourth, CVF, which is known to inactivate complement, abrogated the capability of C5-sufficient mice to respond. Fifth, depleting plasma of hemolytic activity while generating C5a did not affect the capacity of the activated plasma to reconstitute C5-deficient mice. Finally, only the plasma fraction containing molecules of the size range of C5a reconstituted C5-deficient mice. These findings indicate that C5a and not the membrane attack complex is required for HN. Although we do not know through which mechanism C5a participates in the development of HN, we propose that the described HN response is related to a local defense mechanism in which TNF and C5a lead to the disruption of capillaries in the direct vicinity of bacteria. By this mechanism the rapid spread of bacteria or their products into the circulation is prevented. Such a tissue response is consistent with the known higher susceptibility of C5-deficient mice to bacterial infections and provides a model with which to search for the multiple steps involved in this important local defense mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3199066      PMCID: PMC2189157          DOI: 10.1084/jem.168.6.2007

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

2.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.

Authors:  T Spies; C C Morton; S A Nedospasov; W Fiers; D Pious; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

5.  Suppression of the haemorrhagic component of the Schwartzmann reaction by anti-complement serum.

Authors:  L Polák; J L Turk
Journal:  Nature       Date:  1969-08-16       Impact factor: 49.962

6.  Protective function of C6 in rabbits treated with bacterial endotoxin.

Authors:  K J Johnson; P A Ward
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

7.  The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.

Authors:  S Bara; T F Lint
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

8.  Isolation of three separate anaphylatoxins from complement-activated human serum.

Authors:  T E Hugli; C Gerard; M Kawahara; M E Scheetz; R Barton; S Briggs; G Koppel; S Russell
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

9.  Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.

Authors:  C Gerard; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

10.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  13 in total

1.  Glucocorticoid-mediated inhibition of endotoxin-induced intratumor tumor necrosis factor production and tumor hemorrhagic necrosis and regression.

Authors:  R J North; E A Havell
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

2.  Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

3.  A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations.

Authors:  R al Attiyah; H Rosen; G A Rook
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

4.  Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

Authors:  R Beyaert; C De Potter; B Vanhaesebroeck; F Van Roy; W Fiers
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

5.  A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury.

Authors:  Feng Qian; Jing Deng; Ni Cheng; Emily J Welch; Yongliang Zhang; Asrar B Malik; Richard A Flavell; Chen Dong; Richard D Ye
Journal:  EMBO J       Date:  2009-08-20       Impact factor: 11.598

6.  Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis.

Authors:  M I Pellón; A A Steil; V Furió; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

7.  The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin.

Authors:  W Hsueh; X Sun; L N Rioja; F Gonzalez-Crussi
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

8.  Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.

Authors:  Y Wang; S A Rollins; J A Madri; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects.

Authors:  Vishwanath Venketaraman; Tatanisha Rodgers; Rafael Linares; Nancy Reilly; Shobha Swaminathan; David Hom; Ariel C Millman; Robert Wallis; Nancy D Connell
Journal:  AIDS Res Ther       Date:  2006-02-20       Impact factor: 2.250

10.  Shedding of tumor necrosis factor receptors by activated human neutrophils.

Authors:  F Porteu; C Nathan
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.